AI-assisted scoping review of code sharing in clinical prediction model research. Publication: Nature Medicine. Dana-Farber Cancer Institute authors: ...

If you are a journalist and have a question about this story, please call 617-632-4090 and ask to speak to a member of the media team, or email media@dfci.harvard.edu.

An investigational antibody-drug conjugate demonstrated clinically meaningful and durable responses in patients with platinum-resistant ovarian cancer, including patients whose tumors had low or no ...

Boston's renowned Longwood Medical Area (LMA) is one of the world's foremost hubs of advanced medical care and breakthrough research. It is here that Dana-Farber established our headquarters, and it ...

What Is Soft Tissue Sarcoma? Soft tissue sarcoma refers to cancer that begins in the muscle, fat, fibrous tissue, blood vessels, or other supporting tissue of the body. The tumors can be found ...

Dana-Farber's Online Second Opinion Program for adult patients is powered by AccessHope. Once materials collection is complete, it typically takes 7 to 14 business days to receive your written online ...

Dr. Barbie is the Director of the Lowe Center for Thoracic Oncology at Dana-Farber Cancer Institute and a Professor of Medicine at Harvard Medical School. He is also Associate Director of the Belfer ...

Neha Garg, MD - Medical Oncology Dana-Farber Brigham Cancer Center at South Shore Health 101 Columbian Street South Weymouth, MA 02190 ...

Our physician portal, Physician Gateway, helps you keep track of patients you have referred to Dana-Farber Brigham Cancer Center for care. Physician Gateway is available for primary care providers, ...

Dr. Murakami graduated from Washington University School of Medicine with an M.D. and M.A. in Biology and Biomedical Sciences in 2009. He trained in Internal Medicine at the Massachusetts General ...

Dana-Farber Cancer Institute researchers report that all nine patients in a clinical trial being treated for stage III or IV clear cell renal cell carcinoma (a form of kidney cancer), generated a ...

A rare inherited mutation in the Epidermal Growth Factor Receptor (EGFR) gene is associated with a 25-fold increased risk of lung cancer, according to a study by investigators at Dana-Farber Cancer ...